Zobrazeno 1 - 10
of 7 066
pro vyhledávání: '"Lymphoid leukemia"'
Autor:
Lopez-Millan B; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Department of Physiology, University of Granada, Granada, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Rubio-Gayarre A; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Vinyoles M; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Trincado JL; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain., Fraga MF; Fundación para la Investigación Biosanitaria de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología de Asturias, Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Oviedo, Spain.; Nanomaterials and Nanotechnology Research Center, Universidad de Oviedo, Oviedo, Spain., Fernandez-Fuentes N; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Guerrero-Murillo M; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Martinez A; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Velasco-Hernandez T; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Falgàs A; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Panisello C; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain., Valcarcel G; Epigenetic Control of Hematopoiesis Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain., Sardina JL; Epigenetic Control of Hematopoiesis Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain., López-Martí P; 3D Chromatin Organization Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain., Javierre BM; 3D Chromatin Organization Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain., Del Valle-Pérez B; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques, Unitat Associada al Consejo Superior de Investigaciones Científicas, Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra, Barcelona, Spain., García de Herreros A; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques, Unitat Associada al Consejo Superior de Investigaciones Científicas, Departament de Medicina i Ciències de la Vida, Universitat Pompeu Fabra, Barcelona, Spain., Locatelli F; Department of Pediatric Hematology-Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Bambino Gesù Children's Hospital, Rome, Italy., Pieters R; Princess Màxima Center for Pediatric Oncology, Utrecht, The Netherlands., Bardini M; Tettamanti Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy., Cazzaniga G; Tettamanti Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy.; School of Medicine and Surgery, University of Milan Bicocca, Monza, Italy., Rodríguez-Manzaneque JC; GENYO, Centre for Genomics and Oncological Research, Pfizer/Universidad de Granada/Junta de Andalucía, Granada, Spain., Hanewald T; Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia, Goethe University of Frankfurt, Biocenter, Frankfurt/Main, Germany., Marschalek R; Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia, Goethe University of Frankfurt, Biocenter, Frankfurt/Main, Germany., Milne TA; Medical Research Council, Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, National Institute for Health and Care Research, Oxford Biomedical Research Center Hematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Stam RW; Princess Màxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tejedor JR; Fundación para la Investigación Biosanitaria de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias, Instituto Universitario de Oncología de Asturias, Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III, Oviedo, Spain.; Nanomaterials and Nanotechnology Research Center, Universidad de Oviedo, Oviedo, Spain., Menendez P; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Barcelona, Spain.; Instituciò Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Bueno C; Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas Network, Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Barcelona, Spain.
Publikováno v:
Blood [Blood] 2024 Nov 07; Vol. 144 (19), pp. 2002-2017.
Autor:
Janssens DH; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI, USA., Duran M; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Otto DJ; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Translational Data Science IRC, Fred Hutchinson Cancer Center, Seattle, WA, USA., Wu W; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Xu Y; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Kirkey D; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA, USA., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Center of Excellence for Leukemia Studies, St. Jude Children's Research Hospital, Memphis, TN, USA., Yi JS; Pediatric Hematology and Oncology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA., Meshinchi S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA, USA., Sarthy JF; Seattle Children's Research Institute, Seattle, WA, USA., Ahmad K; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. kahmad@fredhutch.org., Henikoff S; Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. steveh@fredhutch.org.; Howard Hughes Medical Institute, Chevy Chase, MD, USA. steveh@fredhutch.org.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 29; Vol. 15 (1), pp. 9341. Date of Electronic Publication: 2024 Oct 29.
Autor:
Al-Nakhle HH; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Monawarah, Saudi Arabia., Yagoub HS; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Monawarah, Saudi Arabia.; Faculty of Medical Laboratory Sciences, Omdurman Islamic University, Omdurman, Sudan., Alrehaili RY; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Monawarah, Saudi Arabia., Shaqroon OA; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Monawarah, Saudi Arabia., Khan MK; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Monawarah, Saudi Arabia., Alsharif GS; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al-Monawarah, Saudi Arabia.
Publikováno v:
PloS one [PLoS One] 2024 Oct 15; Vol. 19 (10), pp. e0304986. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024).
Autor:
Ogino J; Division of Pediatric Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA; Department of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA., Dou Y; Department of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA. Electronic address: yalidou@usc.edu.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Oct; Vol. 300 (10), pp. 107791. Date of Electronic Publication: 2024 Sep 18.
Autor:
Ray J; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA., Clegg B; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA; Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan, USA., Grembecka J; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA; Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: jolantag@umich.edu., Cierpicki T; Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA; Program in Chemical Biology, University of Michigan, Ann Arbor, Michigan, USA; Department of Biophysics, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: tomaszc@umich.edu.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Oct; Vol. 300 (10), pp. 107777. Date of Electronic Publication: 2024 Sep 12.
Autor:
Heckman CA; University of Helsinki.
Publikováno v:
Blood [Blood] 2024 Sep 12; Vol. 144 (11), pp. 1139-1140.
Autor:
Kwon MC; Discovery Oncology, Janssen R&D, Beerse, Belgium., Thuring JW; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Querolle O; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Dai X; Discovery Product Development and Supply, Janssen R&D, Shanghai, China., Verhulst T; Discovery Oncology, Janssen R&D, Beerse, Belgium., Pande V; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Marien A; Discovery Oncology, Janssen R&D, Beerse, Belgium., Goffin D; Discovery Oncology, Janssen R&D, Beerse, Belgium., Wenge DV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Yue H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Cutler JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Jin C; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Perner F; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Hogeling SM; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Shaffer PL; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Jacobs F; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Vinken P; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Cai W; Discovery Product Development and Supply, Janssen R&D, Shanghai, China., Keersmaekers V; Discovery Oncology, Janssen R&D, Beerse, Belgium., Eyassu F; Discovery Oncology, Janssen R&D, Beerse, Belgium., Bhogal B; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Verstraeten K; Discovery Oncology, Janssen R&D, Beerse, Belgium., El Ashkar S; Discovery Oncology, Janssen R&D, Beerse, Belgium., Perry JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Jayaguru P; Translational Research, Janssen R&D, Spring House, PA., Barreyro L; Translational Research, Janssen R&D, Spring House, PA., Kuchnio A; Discovery Oncology, Janssen R&D, Beerse, Belgium., Darville N; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Krosky D; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Urbanietz G; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Verbist B; TMEDS, Janssen R&D, Beerse, Belgium., Edwards JP; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Cowley GS; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Kirkpatrick R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Steele R; Discovery Product Development and Supply, Janssen R&D, Spring House, PA., Ferrante L; Early Development, Janssen R&D, Spring House, PA., Guttke C; Translational Research, Janssen R&D, Spring House, PA., Daskalakis N; Early Development, Janssen R&D, Spring House, PA., Pietsch EC; Discovery Oncology, Janssen R&D, Spring House, PA., Wilson DM; Discovery Product Development and Supply, Janssen R&D, Beerse, Belgium., Attar R; Translational Research, Janssen R&D, Spring House, PA., Elsayed Y; Discovery Oncology, Janssen R&D, Spring House, PA., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA., Schuringa JJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Armstrong SA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.; Division of Hematology/Oncology, Boston Children's Hospital, and Harvard Medical School, Boston, MA., Packman K; Early Development, Janssen R&D, Cambridge, MA., Philippar U; Discovery Oncology, Janssen R&D, Beerse, Belgium.
Publikováno v:
Blood [Blood] 2024 Sep 12; Vol. 144 (11), pp. 1206-1220.
Autor:
Sheridan M; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Maqbool MA; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; GSK Medicines Research Centre, Stevenage, UK., Largeot A; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg., Clayfield L; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Xu J; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Moncaut N; Genome Editing and Mouse Models, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Sellers R; Computational Biology Support, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Whittle J; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Paggetti J; Department of Cancer Research, Tumor Stroma Interactions, Luxembourg Institute of Health, Luxembourg, Luxembourg., Iqbal M; Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Aucagne R; UFR des Sciences de Santé, Inserm U1231, Université de Bourgogne, Team Epi2THM, LipSTIC Labex, Dijon, France., Delva L; UFR des Sciences de Santé, Inserm U1231, Université de Bourgogne, Team Epi2THM, LipSTIC Labex, Dijon, France., Baker SM; Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Lie-A-Ling M; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Kouskoff V; Division of Developmental Biology and Medicine, The University of Manchester, Manchester, UK., Lacaud G; Stem Cell Biology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK. georges.lacaud@cruk.manchester.ac.uk.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Oct 08; Vol. 17 (1), pp. 91. Date of Electronic Publication: 2024 Oct 08.
Autor:
Verbeek TCAI; Princess Máxima Center, Utrecht, The Netherlands., Vrenken KS; Princess Máxima Center, Utrecht, The Netherlands., Arentsen-Peters STCJM; Princess Máxima Center, Utrecht, The Netherlands., Castro PG; Princess Máxima Center, Utrecht, The Netherlands., van de Ven M; Netherlands Cancer Institute, Amsterdam, The Netherlands., van Tellingen O; Netherlands Cancer Institute, Amsterdam, The Netherlands., Pieters R; Princess Máxima Center, Utrecht, The Netherlands., Stam RW; Princess Máxima Center, Utrecht, The Netherlands. R.W.Stam@prinsesmaximacentrum.nl.
Publikováno v:
Communications biology [Commun Biol] 2024 Oct 04; Vol. 7 (1), pp. 1257. Date of Electronic Publication: 2024 Oct 04.
Autor:
Zhang Q; Department of Hematology, The Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei Province, China., Li FM; Department of Hematology, The Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei Province, China., Wang W; Department of Hematology, The Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei Province, China., Zhang ZH; Department of Hematology, The Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei Province, China., Zhang RJ; Department of Hematology, The Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei Province, China., Ma MS; Department of Hematology, The Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei Province, China., Wang LH; Department of Hematology, The Affiliated Hospital of Chengde Medical University, Chengde 067000, Hebei Province, China.
Publikováno v:
Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Oct; Vol. 32 (5), pp. 1323-1333.